HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $5 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Patrick Trucchio has reiterated a 'Buy' rating on Gossamer Bio (NASDAQ:GOSS) and maintained a $5 price target.
July 26, 2023 | 10:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Gossamer Bio's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $5.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $5 indicates the firm's confidence in the stock's potential to reach this price in the short term. This could lead to increased investor interest and potentially a rise in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100